CAM
WST icon

Cresset Asset Management’s West Pharmaceutical WST Stock Holding History

Cresset Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Buy
32,643
+1,598
+5% +$489K 0.04% 256
2026
Q1 		$7.78M Buy
31,045
+3,288
+12% +$818K 0.03% 304
2025
Q4 		$7.64M Sell
27,757
-428
-2% -$117K 0.03% 293
2025
Q3 		$7.39M Buy
28,185
+648
+2% +$157K 0.03% 280
2025
Q2 		$6.03M Sell
27,537
-1,033
-4% -$221K 0.03% 302
2025
Q1 		$6.4M Buy
28,570
+1,022
+4% +$282K 0.03% 312
2024
Q4 		$9.02M Sell
27,548
-2,681
-9% -$844K 0.04% 240
2024
Q3 		$9.07M Buy
30,229
+435
+1% +$133K 0.03% 329
2024
Q2 		$9.81M Buy
29,794
+6,018
+25% +$2.13M 0.04% 285
2024
Q1 		$9.41M Sell
23,776
-4,361
-15% -$1.61M 0.05% 260
2023
Q4 		$9.91M Buy
28,137
+1,270
+5% +$449K 0.06% 212
2023
Q3 		$10.1M Buy
26,867
+569
+2% +$220K 0.04% 213
2023
Q2 		$10.1M Buy
+26,298
New +$9.39M 0.01% 267
2022
Q4 		– Sell
-1,333
Closed -$328K – 912
2022
Q3 		$328K Buy
+1,333
New +$406K ﹤0.01% 645
2022
Q2 		– Sell
-2,373
Closed -$974K – 1101
2022
Q1 		$974K Sell
2,373
-6,309
-73% -$2.47M 0.01% 418
2021
Q4 		$4.07M Buy
8,682
+3,161
+57% +$1.36M 0.04% 171
2021
Q3 		$2.34M Buy
5,521
+2,040
+59% +$860K 0.03% 202
2021
Q2 		$1.25M Buy
3,481
+1,345
+63% +$444K 0.02% 299
2021
Q1 		$602K Buy
+2,136
New +$611K 0.01% 427
2020
Q4 		– Sell
-773
Closed -$212K – 818
2020
Q3 		$212K Sell
773
-305
-28% -$80.7K ﹤0.01% 629
2020
Q2 		$245K Buy
+1,078
New +$212K 0.01% 537
2019
Q2 		– Sell
-1,051
Closed -$116K – 1729
2019
Q1 		$116K Buy
1,051
+116
+12% +$12.1K ﹤0.01% 512
2018
Q4 		$92K Buy
+935
New +$101K 0.01% 345

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cresset Asset Management's WST Position: Q2 2026 in Review

Cresset Asset Management increased its West Pharmaceutical (WST) stake by 5.1% in Q2 2026, buying an estimated $489K and bringing the position to 32,643 shares worth $11.7M. The position accounts for 0.04% of the portfolio, ranked #256.

Cresset Asset Management first reported a position in WST in Q4 2018 and has held it in 23 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Cresset Asset Management held 32,643 shares of West Pharmaceutical worth $11.7M as of Q2 2026.
  • Cresset Asset Management bought 1,598 West Pharmaceutical shares in Q2 2026, an estimated $489K.
  • West Pharmaceutical made up 0.04% of Cresset Asset Management's portfolio in Q2 2026, its #256 holding.
  • Cresset Asset Management first reported a position in West Pharmaceutical in Q4 2018 and has held it in 23 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.